Hamedi A, Akhlaghi F, Meshkat Z, Sezavar M, Nomani H, Meshkat M
ISRN Obstet Gynecol. 2012; 2012:975135.
PMID: 23213557
PMC: 3505638.
DOI: 10.5402/2012/975135.
Filippone C, Bassot S, Betsem E, Tortevoye P, Guillotte M, Mercereau-Puijalon O
J Clin Microbiol. 2012; 50(5):1663-72.
PMID: 22403426
PMC: 3347141.
DOI: 10.1128/JCM.06540-11.
Carneiro-Proietti A, Sabino E, Leao S, Salles N, Loureiro P, Sarr M
AIDS Res Hum Retroviruses. 2012; 28(10):1265-72.
PMID: 22324906
PMC: 3448098.
DOI: 10.1089/AID.2011.0143.
Beilke M
AIDS Res Hum Retroviruses. 2011; 28(2):139-47.
PMID: 22171689
PMC: 3275926.
DOI: 10.1089/AID.2011.0342.
Agranoff D, Varney K, Murphy E
West J Med. 1996; 164(6):481-5.
PMID: 8764621
PMC: 1303622.
Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain.
Calderon E, Rey C, Medrano F, Sanchez-Roman J, Soriano V, Torres Y
Eur J Clin Microbiol Infect Dis. 1995; 14(8):686-90.
PMID: 8565986
DOI: 10.1007/BF01690875.
Frequency of adult T-cell leukaemia/lymphoma and HTLV-I in Ibadan, Nigeria.
Williams C, Alexander S, Bodner A, Levine A, Saxinger C, Gallo R
Br J Cancer. 1993; 67(4):783-6.
PMID: 8471436
PMC: 1968344.
DOI: 10.1038/bjc.1993.142.
Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.
Roberts B, Foung S, Lipka J, Kaplan J, Hadlock K, Reyes G
J Clin Microbiol. 1993; 31(2):260-4.
PMID: 8432811
PMC: 262746.
DOI: 10.1128/jcm.31.2.260-264.1993.
Seroepidemiological survey of HTLV-I infection in French Polynesia, Cook Islands and Fiji.
Chungue E, Boutin J, Le Marchand L, Philippon G, Le Guellec A, Chanteau S
Eur J Epidemiol. 1993; 9(3):347-50.
PMID: 8405324
DOI: 10.1007/BF00146276.
Human T-lymphotropic virus type I seroprevalence among Japanese Americans.
Murphy E, Varney K, Miyasaki N, Moore R, Umekubo J, Watanabe A
West J Med. 1993; 158(5):480-3.
PMID: 8342263
PMC: 1022128.
Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
Bonis J, Baillou A, Barin F, Verdier M, Janvier B, Denis F
J Clin Microbiol. 1993; 31(6):1481-5.
PMID: 8314990
PMC: 265565.
DOI: 10.1128/jcm.31.6.1481-1485.1993.
Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide.
Lillehoj E, Alexander S, Dubrule C, Wiktor S, Adams R, Tai C
J Clin Microbiol. 1990; 28(12):2653-8.
PMID: 2279997
PMC: 268251.
DOI: 10.1128/jcm.28.12.2653-2658.1990.
Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by the immunofluorescence method.
Gallo D, Penning L, Hanson C
J Clin Microbiol. 1991; 29(10):2345-7.
PMID: 1939596
PMC: 270328.
DOI: 10.1128/jcm.29.10.2345-2347.1991.
Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.
Lal R, Heneine W, Rudolph D, Present W, Hofhienz D, Hartley T
J Clin Microbiol. 1991; 29(10):2253-8.
PMID: 1939580
PMC: 270308.
DOI: 10.1128/jcm.29.10.2253-2258.1991.
The epidemiology of HTLV-I infection.
Mueller N
Cancer Causes Control. 1991; 2(1):37-52.
PMID: 1873433
DOI: 10.1007/BF00052359.
Prevalence of human T-lymphotropic virus in civilian applicants for the United States Armed Forces.
Roberts C, Fipps D, Brundage J, Wright S, Goldenbaum M, Alexander S
Am J Public Health. 1992; 82(1):70-3.
PMID: 1536338
PMC: 1694400.
DOI: 10.2105/ajph.82.1.70.
